Clinical Trials Logo

Clinical Trial Summary

We aimed to compare the efficacy for bowel cleansing of a split-dose regimen with a low morning dose of PEG solution (Asymmetric; 25% of the dose is given on the day of the procedure and 75% of the dose is given on the day before) with the standard split-dose regimen in patients undergoing screening and surveillance colonoscopy using a low volume bowel preparation (2L PEG-citrate-simethicone plus Bisacodyl). We enrolled consecutive outpatients undergoing screening and surveillance colonoscopy in a randomized, single-blind, non-inferiority clinical trial. Patients were randomly assigned to: group A, asymmetric split dose regimen (1,5 L of PEG + bisacodyl the day before and 0,5 L 4 hours before colonoscopy); group B, symmetric split dose regimen (1 L of PEG + bisacodyl the day before and 1 L 5 hours before colonoscopy). Primary endpoint was the proportion of adequate bowel cleansing. Moreover, all patients filled in a nurse-administered questionnaire assessing compliance, tolerability and safety of bowel preparation.


Clinical Trial Description

Prospective, randomized, single-blind, non-inferiority trial in adult patients undergoing screening or surveillance colonoscopy. Eligible participants were randomly assigned, according to a computer-generated list with an allocation ratio of 1:1, to receive either asymmetric or symmetric split-dose regimen of a low-volume preparation by investigators who were not involved in the enrolment process. Detailed written instructions were administered to all patients who accepted to participate. A low-fiber diet was prescribed three day before colonoscopy; participants in both groups were instructed to have a light lunch on the day before the colonoscopy and only clear liquid were allowed on the day of the exam. All endoscopic procedures were scheduled between 9:00 AM and 1:00 PM.

The preparation used in the study is a combination of a 2 L sulphate-free iso-osmotic formulation of of PEG-4000 added with citrates and simethicone (PEG-CS) (Lovol-esse; AlfaWassermann, Bologna, Italy. Kit contains 4 pouches, each containing 64.5gr of PEG, to be dissolved in 2 L of water.), and bisacodyl 5 mg tablets (Lovodyl; Alfa-Wassermann, Bologna, Italy).

All subjects were instructed to take 4 bisacodyl tablets at 4:00 PM on the day before the procedure. Subjects allocated to the asymmetric split-dose regimen group were invited to consume at 6:00 PM on the evening before the colonoscopy 3 sachets of PEG-CS in 1,5 L of water in a range from 90 to 120 minutes (about 250 mL every 15 min) and 4 hours before the scheduled procedure 1 sachets in 0,5 L of water in a range from 15 to 30 minutes. Subjects allocated to the symmetric split-dose regimen group were invited to consume at 6:00 PM on the evening before the colonoscopy 2 sachets of PEG-CS in 1 L of water in a range from 60 to 90 minutes and 5 hours before the scheduled procedure 2 sachets in 1 L of water in a range from 60 to 90 minutes.

Unblinded investigators collected demographic and clinical data with medical history. All patients filled in a nurse-administered questionnaire to assess compliance, tolerability and safety of bowel preparation.

Blinded experencied endoscopists performed endoscopic procedure in accordance with colonoscopy quality practice. Data on bowel cleansing (evaluated by using Boston Bowel Preparation Scale), endoscopic procedures and findings (i.e. cancer, polyps, diverticula) were collected. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03146052
Study type Interventional
Source ASST Rhodense
Contact
Status Completed
Phase N/A
Start date March 27, 2017
Completion date May 5, 2017

See also
  Status Clinical Trial Phase
Active, not recruiting NCT05551052 - CRC Detection Reliable Assessment With Blood
Not yet recruiting NCT02754050 - Safety and Feasibility of the Tandem Snare Device N/A
Recruiting NCT02545699 - Prospective Trial to Compare ADR of G-EYE™ Colonoscopy With Standard Colonoscopy N/A
Completed NCT02617992 - Systematic Wide-Field EMR Scar Assessment and Therapy Audit
Completed NCT01688557 - Trial on Innovative Technologies in Colonoscopy N/A
Completed NCT01481337 - Endoscopic Mucosal Colonic Resection and Polypectomy Under Aspirin N/A
Completed NCT02470416 - Prevalence of Small Bowel Polyps in Patients With Sporadic Duodenal Adenomas N/A
Recruiting NCT00237276 - Experience and Enhancement: Improving Colonoscopic Polyp Detection N/A
Completed NCT00234650 - Adenoma Detection Rate With Position Change at Colonoscopy N/A
Recruiting NCT06096948 - Nexpowder to Prevent Delayed Bleeding After Endoscopic Resection N/A
Recruiting NCT05042947 - A New Ligation Using the Double-loop Clips Technique Versus Traditional Techniques in the Treatment of Large Wounds After Endoscopic Resection N/A
Completed NCT02937506 - Patient Satisfaction With Propofol for Out Patient Colonoscopy Phase 4
Active, not recruiting NCT01369758 - MyoSure Hysteroscopic Tissue Removal System Registry Study Phase 4
Completed NCT00979342 - Comparative Sedation Study of the MyoSure Hysteroscopic Tissue Removal System N/A
Completed NCT00553436 - Evaluation of an Endoscopic Suturing System for Tissue Apposition in Colonic Polypectomy N/A
Completed NCT00577083 - Cap-fitted Colonoscopy: a Randomized, Tandem Colonoscopy Study of Adenoma Miss Rates N/A
Recruiting NCT03868605 - Endoscopic Full Thickness Resection Versus Standard Therapy of the Colorectal Neoplasia N/A
Completed NCT01917513 - Prospective Trial to Compare the Clinical Efficiency of G-EYE™ HD Colonoscopy With Standard HD Colonoscopy N/A
Completed NCT01807169 - Recto Colonic Endoscopic Mucosal Resection and Polypectomy Under Clopidogrel Phase 4
Active, not recruiting NCT03708952 - Lifestyle and Dietary Pattern in Relation to Precursor Lesions of Colorectal Cancer and Cardiometabolic Diseases